RETRACTED: Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy
A Retraction of the Original Research Article
Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy
by Shahidi M, Abazari O, Dayati P, Bakhshi A, Zavarreza J and Modarresi MH (2022). Front. Bioeng. Biotechnol. 10:949704. doi: 10.3389/fbioe.2022.949704
The journal retracts the 5 August 2022 article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures and the validity of the data in the article.
Following provision of raw data by the authors, the Chief Editor concluded that the article’s conclusions and assertions were not sufficiently supported by the findings from the material provided; therefore, the article has been retracted. The authors did not agree to this retraction.
Citation: Frontiers Editorial Office (2024) Retraction: Multicomponent siRNA/miRNA-loaded modified mesoporous silica nanoparticles targeted bladder cancer for a highly effective combination therapy. Front. Bioeng. Biotechnol. 12:1478191. doi: 10.3389/fbioe.2024.1478191
Received: 09 August 2024; Accepted: 16 August 2024;
Published: 21 August 2024.
Approved by:
Gianni Ciofani, Italian Institute of Technology (IIT), ItalyCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org